IL69389A0 - 4h-1,4-benzothiazines,their preparation and pharmaceutical compositions containing them - Google Patents

4h-1,4-benzothiazines,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL69389A0
IL69389A0 IL69389A IL6938983A IL69389A0 IL 69389 A0 IL69389 A0 IL 69389A0 IL 69389 A IL69389 A IL 69389A IL 6938983 A IL6938983 A IL 6938983A IL 69389 A0 IL69389 A0 IL 69389A0
Authority
IL
Israel
Prior art keywords
halogen
aryl
hydroxyl
alkyl
mono
Prior art date
Application number
IL69389A
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL69389A0 publication Critical patent/IL69389A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Dental Preparations (AREA)
  • Ink Jet (AREA)
  • Eyeglasses (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

1. 4H-1,4-Benzothiazines of the formula see diagramm : EP0100527,P16,F4 in which R**1 denotes hydrogen, aryl with 6 to 20 carbon atoms, which can optionally be mono- to trisubstituted by halogen, trifluoromethyl or nitro, 2-thienyl, 3-thienyl, 2-furyl, 3-furyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, 2-pyrimidyl, 4-pyrimidyl or 5-pyrimidyl, which can optionally be mono- or polysubstituted by alkyl, alkoxy, hydroxyl or halogen, cyano or the group see diagramm : EP0100527,P16,F6 in which R**6 represents alkyl (C1 to C8 ), aryl (C6 to C20 ), amino, pyrrolidino, piperidino, morpholino, cycloalkoxy or the radical -O-CH2 -R**8 in which R**8 denotes straight-chain or branched alkyl with 1 to 7 carbon atoms, which is optionally mono- to trisubstituted by halogen, C6 to C20 -aryl, hydroxyl, alkoxy, alkylthio or cyano, R**2 denotes alkyl (C1 to C8 ), which is optionally mono- to trisubstituted by halogen, pyrrolidino, piperidiono, aryl (C1 to C20 ) or by the group in which R**7 represents aryl (C6 to C20 ), hydroxyl, amino, dialkylamino, pyrrolidino, piperidino or morpholino, R**3 denotes hydrogen or one of the groups mentioned under R**2 , and R**4 and R**5 are identical or different and denote hydrogen, halogen, hydroxyl, alkoxy, nitro or cyano, or one of the groups mentioned under R**2 , for therapeutic use.
IL69389A 1982-08-04 1983-08-01 4h-1,4-benzothiazines,their preparation and pharmaceutical compositions containing them IL69389A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823229121 DE3229121A1 (en) 1982-08-04 1982-08-04 4H-1,4-BENZOTHIAZINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT

Publications (1)

Publication Number Publication Date
IL69389A0 true IL69389A0 (en) 1983-11-30

Family

ID=6170116

Family Applications (1)

Application Number Title Priority Date Filing Date
IL69389A IL69389A0 (en) 1982-08-04 1983-08-01 4h-1,4-benzothiazines,their preparation and pharmaceutical compositions containing them

Country Status (14)

Country Link
EP (1) EP0100527B1 (en)
JP (1) JPS5944368A (en)
KR (1) KR840005727A (en)
AT (1) ATE24724T1 (en)
AU (1) AU1758683A (en)
DE (2) DE3229121A1 (en)
DK (1) DK354483A (en)
ES (1) ES524708A0 (en)
FI (1) FI832782A (en)
GR (1) GR79356B (en)
IL (1) IL69389A0 (en)
NO (1) NO832664L (en)
PT (1) PT77096B (en)
ZA (1) ZA835674B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3426564A1 (en) * 1984-07-19 1986-01-30 Bayer Ag, 5090 Leverkusen USE OF 4H-1,4-Benzothiazines FOR PREVENTION AND TREATMENT OF RESPIRATORY DISORDERS, inflammation / RHEUMA, THROMBOEMBOLIC ILLNESSES AND ischemia infarcts, HERZRHYTHMUSSTOERUNGEN, ATHEROSCLEROSIS AND dermatoses, PURPOSE AND ACTIVE DRUGS TO THIS IN THESE PRODUCTS CONTAIN
DE3540702A1 (en) * 1985-11-16 1987-05-21 Bayer Ag 1H-PYRIDO- (2,3-B) (1,4) THIAZINE
DE3545097A1 (en) * 1985-12-19 1987-07-02 Bayer Ag 1-H-PYRIDO- (3,2-B) (1,4) THIAZINE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4397849A (en) * 1980-12-30 1983-08-09 Fujisawa Pharmaceutical Co., Ltd. Benzothiazine derivatives
DE3111487A1 (en) * 1981-03-24 1982-12-30 Bayer Ag, 5090 Leverkusen METHOD FOR PRODUCING 2,3-DIHYDRO-4H-1,4 DIHYDRO-1,4-BENZOTHIAZINES

Also Published As

Publication number Publication date
AU1758683A (en) 1984-02-09
DK354483D0 (en) 1983-08-03
ES8404682A1 (en) 1984-05-01
DE3229121A1 (en) 1984-02-09
KR840005727A (en) 1984-11-16
FI832782A (en) 1984-02-05
JPS5944368A (en) 1984-03-12
GR79356B (en) 1984-10-22
PT77096B (en) 1986-03-12
EP0100527B1 (en) 1987-01-07
NO832664L (en) 1984-02-06
FI832782A0 (en) 1983-08-02
ES524708A0 (en) 1984-05-01
EP0100527A1 (en) 1984-02-15
ZA835674B (en) 1984-04-25
PT77096A (en) 1983-08-01
DE3368925D1 (en) 1987-02-12
DK354483A (en) 1984-02-05
ATE24724T1 (en) 1987-01-15

Similar Documents

Publication Publication Date Title
EP0280474A3 (en) Macromolecular platinum antitumor compounds
ZA811500B (en) Heterocyclic compounds,process for their preparation and pharmaceutical compositions containing them
MC1390A1 (en) PYRAZOLOPYRIDAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2311776A1 (en) 2,4-DIAMINO-5-CHLORO-6 PYRIMIDINES AND PROCESS FOR THEIR PREPARATION
ES2121993T3 (en) DERIVATIVES OF 4-OXO-2-THIOXOIMIDAZOLIDINE AS INHIBITING SUBSTANCES OF THE BLOOD PLATE AGGREGATION.
IL78666A0 (en) Pyridine derivatives,their preparation and pharmaceutical compositions containing them
EP0200024A3 (en) 3-cyano-pyridines, process for their preparation and their pharmaceutical use
GR78806B (en)
PT75074A (en) Process for preparing cestain pyrimidone derivatives and composition containing their
IL69389A0 (en) 4h-1,4-benzothiazines,their preparation and pharmaceutical compositions containing them
DE3167712D1 (en) Process for the preparation of chloropyridines substituted with methyl or trifluoromethyl groups
FR2417502A1 (en) NEW SUBSTITUTED 2-PHENYLIMINO-IMIDAZOLIDINES, THEIR ADDITIONAL SALTS WITH ACIDS, MEDICINAL PRODUCTS CONTAINING THEM AND METHODS FOR THEIR PREPARATION
ES8603835A1 (en) Pyridine derivatives, process for their preparation and pharmaceutical compositions containing them.
PT84819A (en) Process for preparing 2-pyridil-penem compounds
ES8304937A1 (en) Derivatives of substituted 2-amino-pyridine, process for their preparation, their use in medicaments and preparation thereof.
DK152499C (en) ANALOGY PROCEDURE FOR PREPARATION OF 2-AMINO-8-CYCLOPROPYL-5-OXO-5,8-DIHYDRO-PYRIDOOE2,3-DAAPYRIMIDINE-6-CARBOXYL ACID
FR2612188B1 (en) 3- (2-HALOALKYL) -1,4-OXATHIINS AND 2- (2-HALOALKYL) -0,4-DITHIINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHOD FOR THE TREATMENT OF LEUKEMIA AND TUMORS USING THEM
YU82676A (en) Furnace for thermally treating solid lump fuel
PT84101A (en) NOVEL AMIDES SUBSTITUTED FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ES8800922A1 (en) Benzodioxole derivatives, process for their preparation and pharmaceutical compositions.
EP0011845A3 (en) Antiseborrhoeic hair treatment composition
PT65122A (en) 2,4-DIAMINO BROMO-5-CHLORO-6-PYRIMIDINES FOR USE AS MEDICAMENTS AND PROCESS FOR PREPARATION
BE776278A (en) 8-AMINO THEOPHYLLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITION CONTAINING THEM
IT8247590A0 (en) HETEROCYCLIC PYRIMIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND PROCEDURE FOR PREPARING THEM
BE893833A (en) PROCESS FOR THE PREPARATION OF 3- (3,6-DIHYDRO-1 (2H) - PYRIDYL) -PYRIMIDINES 3-OXIDES